▽
|
NXDT |
NexPoint Diversified Real Estat |
Real Estate |
1.8 |
8.1 |
37.0 |
0 |
|
-1.9 |
0.2 |
-2.9 |
-13.2 |
-51.10 |
155.8 |
|
|
80.58 |
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 |
2024-10-30 |
NXDT's primary investment objective is to provide both current income and capital appreciation. Target underlying property types include but are not limited to industrial, hospitality, net lease, retail, office, storage and healthcare. NXDT also may, |
▽
|
NXPI |
NXP Semiconductors N.V. |
Technology |
26.4 |
1.8 |
58.0 |
5 |
36.9 |
23.3 |
7.5 |
11.0 |
32.4 |
-12.97 |
21.1 |
1.91 |
1.39 |
35.49 |
3, 6, 9, 12 |
2024-10-30 |
NXP Semiconductors N.V. offers various semiconductor products. Its products are used in various applications, including automotive, industrial and Internet of Things, mobile, and communication infrastructure. The company markets its products to various original |
▽
|
NXRT |
NexPoint Residential Trust, Inc |
Real Estate |
27.7 |
5.2 |
13.9 |
8 |
98.8 |
24.7 |
2.2 |
1.7 |
|
-9.47 |
15.9 |
1.13 |
|
23.47 |
3, 6, 9, 12 |
2024-10-30 |
NXRT is focused on acquiring, owning and operating well-located middle-income multifamily properties with "value-add" potential. NXRT is externally advised by NexPoint Real Estate Advisors, L.P., an |
▽
|
NXST |
Nexstar Media Group, Inc. |
Communication Services |
53.7 |
3.6 |
27.6 |
10 |
50.3 |
16.5 |
2.5 |
10.7 |
15.1 |
-2.77 |
7.0 |
1.53 |
|
19.03 |
2, 5, 8, 11 |
2024-10-30 |
Nexstar Media Group, Inc. produces and distributes engaging local and national news, sports and entertainment content across the television and digital platforms in the United States. It owns, operates, programs, or provides sales and other services to |
▽
|
NXT |
Nextracker Inc. |
Technology |
|
|
|
None |
|
15.1 |
4.8 |
2.1 |
|
-21.75 |
12.3 |
1.98 |
1.76 |
38.15 |
|
2024-10-30 |
Nextracker Inc. provides solar tracker and software solutions for utility-scale and distributed generation solar projects in the United States and internationally. The company offers NX Horizon, a solar tracking solution; and NX Horizon-XTR, a terrain |
▽
|
NYCB |
New York Community Bancorp, Inc |
Financial Services |
17.3 |
6.7 |
29.0 |
0 |
|
-54.0 |
0.5 |
-0.2 |
-0.9 |
-27.37 |
-2.2 |
|
|
7.34 |
1, 2, 4, 5, 6, 7, 8, 9, 10, 11 |
2024-10-30 |
New York Community Bancorp, Inc. operates as the bank holding company for Flagstar Bank, N.A. The company's deposit products include interest-bearing checking and money market, savings, non-interest-bearing, and |
▽
|
NYMT |
New York Mortgage Trust, Inc. |
Real Estate |
8.3 |
15.4 |
20.6 |
0 |
|
-10.1 |
0.3 |
-0.5 |
-3.1 |
869.14 |
-15.8 |
|
|
21.34 |
1, 3, 4, 6, 7, 9, 10, 12 |
2024-10-30 |
New York Mortgage Trust, Inc. acquires, invests in, finances, and manages mortgage-related single-family and multi-family residential assets in the United States. The company also qualifies as a real estate investment trust for federal income |
▽
|
NYT |
New York Times Company (The) |
Communication Services |
14.5 |
0.9 |
23.6 |
5 |
29.5 |
39.4 |
5.2 |
1.4 |
|
-9.67 |
9.6 |
1.28 |
|
64.95 |
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 |
2024-10-30 |
The New York Times Company, together with its subsidiaries, creates, collects, and distributes news and information worldwide. It operates through two segments, The New YorkTimes Group and The Athletic. The company also offers The Athletic, a sports |
▽
|
O |
Realty Income Corporation |
Real Estate |
15.4 |
5.6 |
16.9 |
27 |
305.7 |
60.3 |
1.6 |
1.0 |
2.6 |
-25.55 |
21.4 |
1.53 |
1.52 |
57.01 |
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 |
2024-10-30 |
Realty Income, The Monthly Dividend Company, is an S&P 500 company. The company is structured as a real estate investment trust ("REIT"), and its monthly dividends are supported by the cash flow from over 15, |
▽
|
OABI |
OmniAb, Inc. |
Healthcare |
6.9 |
|
|
None |
|
-9.2 |
1.5 |
-0.4 |
|
-0.43 |
-148.2 |
4.11 |
|
83.84 |
|
2024-10-30 |
OmniAb, Inc. engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its |